NCT04089631View on ClinicalTrials.gov

Circulating Tumour DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II Evaluation

PHASE3RecruitingINTERVENTIONAL
Enrollment

4,812

Participants

Timeline

Start Date

June 26, 2020

Primary Completion Date

June 30, 2023

Study Completion Date

June 30, 2026

Conditions
Colon Cancer Stage II
Interventions
DRUG

Capecitabine

6 months capecitabine, in combination with oxaliplatin 3 to 6 months capecitabine

Trial Locations (1)

01307

RECRUITING

Universitaetsklinikum Carl Gustav Carus, Medizinische Klinik, Dresden

All Listed Sponsors
lead

Technische Universität Dresden

OTHER